Pharmacists in Winchester, CA Accepting Medicare
9 Pharmacists found. Showing 1 - 9
 Chloe Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30736 Benton Rd, Winchester, CA 92596 Phone: 951-926-1223 |
Dr. Supannee Sandra Lertpaichaiyon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 32627 Presidio Hills Ln, Winchester, CA 92596 Phone: 310-945-6398 |
 David Samir Estaphnous, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30736 Benton Rd, Winchester, CA 92596 Phone: 951-926-1223 |
Satish Baldha Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30736 Benton Rd, Winchester, CA 92596 Phone: 951-926-1223 |
Morgan Britney Barron Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30736 Benton Rd, Winchester, CA 92596 Phone: 951-926-1223 Fax: 951-926-1454 |
Dr. Christie Nadene Fanous, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30736 Benton Rd, Winchester, CA 92596 Phone: 951-902-9476 |
Dr. Ildiko Venczel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30712 Benton Rd, Winchester, CA 92596 Phone: 951-325-2523 |
Preston Johnson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30736 Benton Rd, Winchester, CA 92596 Phone: 951-926-1223 |
Lakhvir Kaur, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 30712 Benton Rd, Winchester, CA 92596 Phone: 951-325-2523 |
News Archive
Patients with particular genetic variation more prone to drug-induced pancreatitis
Doctors have discovered that patients with a particular genetic variation are four times more likely to develop pancreatitis if they are prescribed a widely used group of drugs.
IMUC signs exclusive licensing agreement with Targepeutics for acquisition of IL-13Ra2 receptor
ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.
Birth weight may identify future metabolic risks in girls
Heavier female babies are more likely to develop diabetes and related metabolic risks when they grow up compared with their male counterparts, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology and Metabolism.
Hepatitis C therapy peginterferon alfa-2b shows promise
The hepatitis C therapy peginterferon alfa-2b, when given as low-dose maintenance therapy, can prevent disease progression in certain patients who failed previous interferon-based hepatitis C therapies and have advanced liver disease, according to findings from a large, four-year study presented today at the 43rd annual meeting of the European Association for the Study of the Liver (EASL).
› Verified 7 days ago
Pharmacists
Counselors
Marriage Counselors
Clinical Social Workers
Dentists